Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Belzupacap sarotalocan by Aura Biosciences for Muscle Invasive Bladder Cancer (MIBC): Likelihood of Approval
Belzupacap sarotalocan is under clinical development by Aura Biosciences and currently in Phase I for Muscle Invasive Bladder Cancer (MIBC)....
Belzupacap sarotalocan by Aura Biosciences for Uveal Melanoma: Likelihood of Approval
Belzupacap sarotalocan is under clinical development by Aura Biosciences and currently in Phase III for Uveal Melanoma. According to GlobalData,...
Risk adjusted net present value: What is the current valuation of Aura Biosciences's Belzupacap sarotalocan?
Belzupacap sarotalocan is a recombinant protein commercialized by Aura Biosciences, with a leading Phase III program in Uveal Melanoma. According...